[
    [
        {
            "time": "",
            "original_text": "[审慎增持评级]凯莱英(002821)年报及季报点评：业绩保持稳定增长 未来国内市场潜力较大",
            "features": {
                "keywords": [
                    "凯莱英",
                    "年报",
                    "季报",
                    "业绩",
                    "稳定增长",
                    "国内市场",
                    "潜力"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[审慎增持评级]凯莱英(002821)年报及季报点评：业绩保持稳定增长 未来国内市场潜力较大",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医疗保健：港股新规推动创新医药公司上市 荐10股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "港股",
                    "新规",
                    "创新医药",
                    "上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "港股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗保健：港股新规推动创新医药公司上市 荐10股",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "药明康德将于今日申购 四股或迎腾飞契机",
            "features": {
                "keywords": [
                    "药明康德",
                    "申购",
                    "腾飞",
                    "契机"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德将于今日申购 四股或迎腾飞契机",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]